Study Of Adults And Adolescents With Vasomotor Rhinitis

Summary

The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with vasomotor rhinitis (VMR).

Timeline

Start

2005-07-11

Primary completion

2006-02-09

Completion

2006-02-09

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs Fluticasone Furoate 110 mcg QD; p = 0.050; Mean Difference (Net) -0.335 (95% CI -0.67 to 0.00); ANCOVA NCT00117325 ↗

Drugs

Indications